Emtricitabine + Rilpivirine + Tenofovir Alafenamide

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Brands with this exact combination

BrandComposition & strengthManufacturer
Emtricitabine/Rilpivirine/Tenofovir Alafenamide ViatrisCZ EU LV
  • tablet ×6 Emtricitabine 200 mg + Rilpivirine + Tenofovir Alafenamide
  • tablet ×6 Emtricitabine 200 mg + Rilpivirine 25 mg + Tenofovir Alafenamide 25 mg
  • unknown Emtricitabine + Rilpivirine + Tenofovir Alafenamide
VIATRIS LIMITED, Dublin
Emtricitabine 200mg / Rilpivirine 25mg / Tenofovir alafenamide 25mg tabletsAU ES GB200 mg / 25 mgGilead Sciences Ireland Unlimited Company
emtricitabina + rilpivirina + tenofovir alafenamidaES200 mg / 25 mgGilead Sciences Ireland Unlimited Company
tenofovir alafenamide succinate + emtricitabine + rilpivirine hydrochloride + tenofovir alafenamide + rilpivirineAU——
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamideUS200 mg / 25 mgGilead Sciences, Inc.
EMTRICITABINA/RILPIVIRINA/TENOFOVIR ALAFENAMIDA VIATRISES
  • tablet Emtricitabine 200 mg + Rilpivirine 25 mg + Tenofovir Alafenamide 25 mg
Viatris Limited
RILPEMVIAU
  • unknown Emtricitabine + Rilpivirine + Tenofovir Alafenamide
—
TRILPIVIAU
  • unknown Emtricitabine + Rilpivirine + Tenofovir Alafenamide
—
安以斯膜衣錠TW
  • tablet Emtricitabine + Rilpivirine + Tenofovir Alafenamide
嬌生股份有限公司
ODEFSEY emtricitabine (200 mg), rilpivirine (25 mg), tenofovir alafenamide (25 mg) fixed-dose combination tabletAU
  • tablet Emtricitabine 200 mg + Rilpivirine 27.5 mg + Tenofovir Alafenamide 28.04 mg
Gilead Sciences Pty Ltd
ODOFORIL emtricitabine 200 mg / rilpivirine (as hydrochloride) 25 mg / tenofovir alafenamide (as fumarate) 25 mg film coated tablet bottleAU
  • tablet Emtricitabine 200 mg + Rilpivirine 27.5 mg + Tenofovir Alafenamide 31.09 mg
Alphapharm Pty Ltd
RILPEMVI emtricitabine 200 mg, rilpivirine (as hydrochloride) 25 mg, tenofovir alafenamide (as succinate) 25 mg tablet bottleAU
  • tablet Emtricitabine 200 mg + Rilpivirine 27.5 mg + Tenofovir Alafenamide 31.194 mg
Lupin Australia Pty Limited
TRILPIVI emtricitabine 200 mg, rilpivirine (as hydrochloride) 25 mg, tenofovir alafenamide (as succinate) 25 mg tablet bottleAU
  • tablet Emtricitabine 200 mg + Rilpivirine 27.5 mg + Tenofovir Alafenamide 31.194 mg
Lupin Australia Pty Limited
オデフシィ配合錠JP
  • tablet Emtricitabine + Rilpivirine + Tenofovir Alafenamide
ヤンセンファーマ

Same combination in other markets

These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.